Study results may provide guidance for healthcare policy and pandemic management at a selective, local level.
Vaccines are a key public health strategy that is remarkably safe due to continued postmarketing surveillance programs.
Ritonavir may increase the risk for bradycardia among critically ill patients with COVID-19.
New study is the first focused analysis of bacterial diversity in the urogenital tract of postmenopausal women, according to investigators.
Researchers found limited clinical variability between PIV serotypes and substantial overlap in presenting signs and symptoms for PIV and other etiologies.
Genomically-confirmed assessments of the risk for CDI found that asymptomatic carriers serve as viral reservoirs in clinical settings.
Hispanics and blacks are most likely to stay home if experiencing medical emergencies, like a heart attack or stroke, to avoid the risk of contracting COVID-19 at the hospital.
Young children with mild-to-moderate COVID-19 have higher amounts of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA in their nasopharynx than older children and adults.
Research results underscore the importance of understanding the characteristics of Legionnaires’ disease and the need for early diagnosis.
A phase 3 study of tocilizumab (Actemra®) for the treatment of hospitalized patients with severe COVID-19 pneumonia did not meet its primary and key secondary end points.
Lack of parental intent to initiate and complete the human papillomavirus (HPV) vaccine series for adolescents is a major public health concern.
Factors linked to structural racism and social determinants of health are associated with an increased risk for COVID-19 in Latino communities.
The FDA has granted Orphan Drug designation to INO-3107, a DNA plasmid immunotherapy, for the treatment of recurrent respiratory papillomatosis, a rare disease caused by human papillomavirus types 6 and 11 infections.
In this study, emergency, unregistered use of acalabrutinib was available to patients hospitalized with advanced COVID-19 in accordance with the WHO MEURI guidelines.
Infection may be associated with an increased risk for early stroke recurrence in hospitalized patients with acute ischemic stroke.
Nirsevimab prevents respiratory syncytial virus (RSV)-associated lower respiratory tract infections in healthy preterm infants, while maternal RSV fusion (F) protein nanoparticle vaccination did not meet the prespecified criterion for efficacy.
Both nasal/throat and nasopharyngeal swabs demonstrated similar sensitivity when testing healthcare workers with symptoms of COVID-19.
Depression and anxiety exhibited in COVID-19 patients may be a sign that the virus impacts the central nervous system.
COVID-19 is associated with hyperglycemic emergencies, particularly in patients with existing type 2 diabetes and of African ethnicity.
The U.S. Centers for Disease Control and Prevention plans to take steps to improve how it collects COVID-19 data for blacks, Hispanics, and Native Americans.